Epigenetic Regulation Mediated by Sphingolipids in Cancer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
10 Mar 2023
Historique:
received: 03 02 2023
revised: 02 03 2023
accepted: 06 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Epigenetic changes are heritable modifications that do not directly affect the DNA sequence. In cancer cells, the maintenance of a stable epigenetic profile can be crucial to support survival and proliferation, and said profile can differ significantly from that of healthy cells. The epigenetic profile of a cancer cell can be modulated by several factors, including metabolites. Recently, sphingolipids have emerged as novel modulators of epigenetic changes. Ceramide and sphingosine 1-phosphate have become well known in cancer due to activating anti-tumour and pro-tumour signalling pathways, respectively, and they have recently been shown to also induce several epigenetic modifications connected to cancer growth. Additionally, acellular factors in the tumour microenvironment, such as hypoxia and acidosis, are now recognised as crucial in promoting aggressiveness through several mechanisms, including epigenetic modifications. Here, we review the existing literature on sphingolipids, cancer, and epigenetic changes, with a focus on the interaction between these elements and components of the chemical tumour microenvironment.

Identifiants

pubmed: 36982369
pii: ijms24065294
doi: 10.3390/ijms24065294
pmc: PMC10048860
pii:
doi:

Substances chimiques

Sphingolipids 0
Ceramides 0
Sphingosine NGZ37HRE42

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Italian Association for Cancer Research
ID : 21403

Références

Trends Cell Biol. 2009 May;19(5):207-17
pubmed: 19342239
Mol Cell. 2008 May 23;30(4):460-71
pubmed: 18498749
Semin Cancer Biol. 2017 Apr;43:119-133
pubmed: 28188829
Cell. 2007 Feb 23;128(4):693-705
pubmed: 17320507
Cancer Res. 2005 Dec 15;65(24):11236-40
pubmed: 16357124
Adv Enzyme Regul. 2010;50(1):349-62
pubmed: 19914275
Trends Cell Biol. 2005 Jun;15(6):312-8
pubmed: 15953549
Cell Biochem Biophys. 2021 Sep;79(3):575-592
pubmed: 34085165
Cancer Res. 2010 Dec 1;70(23):9905-15
pubmed: 21118968
Cell. 2001 Jan 12;104(1):119-30
pubmed: 11163245
Cancers (Basel). 2021 Jan 15;13(2):
pubmed: 33467731
Annu Rev Biochem. 2013;82:637-62
pubmed: 23527695
Nucleic Acids Res. 2016 Feb 18;44(3):1105-17
pubmed: 26464434
Cancers (Basel). 2021 Jul 30;13(15):
pubmed: 34359749
Br Med Bull. 1997;53(3):539-53
pubmed: 9374036
Int J Mol Sci. 2018 Aug 26;19(9):
pubmed: 30149660
Nat Genet. 2005 Apr;37(4):391-400
pubmed: 15765097
Curr Opin Chem Biol. 2019 Aug;51:11-17
pubmed: 30825741
Cancer Biol Ther. 2013 Oct 1;14(10):962-72
pubmed: 24025258
Cancer Metastasis Rev. 2019 Jun;38(1-2):205-222
pubmed: 30911978
Cancers (Basel). 2019 Sep 30;11(10):
pubmed: 31575057
Exp Cell Res. 2012 Jan 1;318(1):43-52
pubmed: 22024383
FEBS Lett. 1999 Jan 22;443(1):25-30
pubmed: 9928946
Nat Struct Mol Biol. 2014 Nov;21(11):949-54
pubmed: 25372310
Cell Signal. 2011 Jul;23(7):1144-52
pubmed: 21385609
J Neurosci Res. 2008 Feb 15;86(3):537-43
pubmed: 17893925
J Natl Cancer Inst. 2001 Nov 21;93(22):1698-703
pubmed: 11717330
Nat Rev Cancer. 2017 Oct;17(10):577-593
pubmed: 28912578
Adv Exp Med Biol. 2021;1283:1-16
pubmed: 33155134
Biol Chem. 2017 Nov 27;398(12):1319-1325
pubmed: 28742512
FASEB J. 2007 Oct;21(12):3386-97
pubmed: 17548428
Mol Biol Cell. 2012 Aug;23(16):3156-66
pubmed: 22718902
J Biol Chem. 2002 Jul 12;277(28):25748-55
pubmed: 11948178
Nature. 2005 Jun 9;435(7043):828-33
pubmed: 15944707
Trends Biochem Sci. 2016 Mar;41(3):211-218
pubmed: 26778478
Adv Biol Regul. 2017 Jan;63:122-131
pubmed: 27771292
Int J Cancer. 2009 Nov 1;125(9):2114-21
pubmed: 19618460
EMBO J. 2003 Oct 15;22(20):5491-500
pubmed: 14532121
Am J Cancer Res. 2016 Mar 15;6(4):859-75
pubmed: 27186436
Genes Cells. 2005 Jun;10(6):605-15
pubmed: 15938718
Food Chem Toxicol. 2008 Apr;46(4):1346-59
pubmed: 17976883
IUBMB Life. 2000 Aug;50(2):119-24
pubmed: 11185956
JCO Precis Oncol. 2017;2017:
pubmed: 29354796
Open Med (Wars). 2021 Jul 22;16(1):1083-1089
pubmed: 34322597
Science. 1996 Apr 19;272(5260):408-11
pubmed: 8602529
Science. 2019 Mar 15;363(6432):1222-1226
pubmed: 30872526
Epigenetics. 2013 Feb;8(2):131-7
pubmed: 23324617
Bioessays. 1998 Aug;20(8):615-26
pubmed: 9780836
Breast Cancer Res. 2021 Nov 4;23(1):103
pubmed: 34736510
Adv Exp Med Biol. 2010;688:1-23
pubmed: 20919643
Tumour Biol. 2016 May;37(5):6331-6
pubmed: 26628299
Biochim Biophys Acta. 2002 May 23;1582(1-3):8-17
pubmed: 12069805
Cancer Cell Int. 2019 Nov 14;19:295
pubmed: 31807117
Int J Mol Sci. 2022 Nov 23;23(23):
pubmed: 36498891
Biochem J. 2012 Nov 1;447(3):457-64
pubmed: 22908849
Int J Mol Sci. 2021 Aug 31;22(17):
pubmed: 34502385
Acta Pharm Sin B. 2015 Sep;5(5):378-89
pubmed: 26579469
Cancer Res. 2012 Feb 1;72(3):726-35
pubmed: 22298596
Nat Rev Mol Cell Biol. 2008 Mar;9(3):206-18
pubmed: 18292778
Cancers (Basel). 2020 Apr 23;12(4):
pubmed: 32340362
Cell. 2012 Feb 3;148(3):399-408
pubmed: 22304911
J Mass Spectrom. 2022 Aug;57(8):e4880
pubmed: 36028991
Science. 2009 Sep 4;325(5945):1254-7
pubmed: 19729656
Biomolecules. 2022 Oct 21;12(10):
pubmed: 36291742
Trends Genet. 2021 Jun;37(6):566-581
pubmed: 33485674
J Pers Med. 2022 Mar 14;12(3):
pubmed: 35330456
Kidney Int. 1997 Feb;51(2):553-5
pubmed: 9027737
Neuropsychopharmacology. 2013 Jan;38(1):23-38
pubmed: 22781841
Signal Transduct Target Ther. 2016 Jan 28;1:15004
pubmed: 29263891
J Biol Chem. 2003 Nov 21;278(47):46832-9
pubmed: 12954646
Cell Rep. 2022 May 10;39(6):110796
pubmed: 35545051
Cancer Cell. 2012 May 15;21(5):655-667
pubmed: 22624715
Science. 2001 Nov 9;294(5545):1337-40
pubmed: 11598268
J Neuroinflammation. 2017 Jun 2;14(1):111
pubmed: 28577576
Hypoxia (Auckl). 2015 Dec 11;3:83-92
pubmed: 27774485
Curr Biol. 2020 Aug 17;30(16):R921-R925
pubmed: 32810447
FASEB J. 2020 Mar;34(3):4293-4310
pubmed: 32017264
Carcinogenesis. 2004 Jul;25(7):1227-36
pubmed: 14976134
EMBO Mol Med. 2015 Apr 07;7(6):714-34
pubmed: 25851537
Cell Metab. 2018 Feb 6;27(2):281-298
pubmed: 29129785
Cell Metab. 2016 Aug 9;24(2):311-23
pubmed: 27508876
Nature. 2000 Jan 6;403(6765):41-5
pubmed: 10638745
Curr Opin Genet Dev. 2003 Apr;13(2):143-53
pubmed: 12672491
Oncotarget. 2016 Oct 4;7(40):64886-64899
pubmed: 27588496
J Biol Chem. 2007 Sep 14;282(37):27493-27502
pubmed: 17635916
Cell Biochem Funct. 2019 Jun;37(4):281-289
pubmed: 31038222
Biochim Biophys Acta. 2014 May;1841(5):692-703
pubmed: 24355909
Genes Dev. 2009 Apr 1;23(7):781-3
pubmed: 19339683
Exp Ther Med. 2021 Jun;21(6):577
pubmed: 33850549
Biomark Res. 2019 Oct 31;7:23
pubmed: 31695915
Int J Biochem Cell Biol. 2016 May;74:152-60
pubmed: 26923291
Science. 2009 Jun 5;324(5932):1289-93
pubmed: 19498162
Cell Rep. 2016 Jun 28;16(1):37-47
pubmed: 27320910
Oncol Res. 1997;9(6-7):327-32
pubmed: 9406238
PLoS Genet. 2010 Apr 22;6(4):e1000917
pubmed: 20421991
Theranostics. 2021 Jan 1;11(3):1473-1492
pubmed: 33391546
Nucleic Acids Res. 2021 Jun 21;49(11):6043-6052
pubmed: 33885816
Nat Rev Genet. 2007 Apr;8(4):286-98
pubmed: 17339880
Chem Rev. 2015 Mar 25;115(6):2255-73
pubmed: 25495456
Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13510-5
pubmed: 21825155
Adv Exp Med Biol. 2010;688:118-30
pubmed: 20919650
Mol Cell Biol. 2005 Apr;25(8):2873-84
pubmed: 15798178
Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2715-26
pubmed: 25449995
Histol Histopathol. 2000 Jul;15(3):921-8
pubmed: 10963134
Mol Cell. 2010 Jun 25;38(6):864-78
pubmed: 20620956
Cancer Res. 2009 Mar 15;69(6):2443-52
pubmed: 19258511
Cilia. 2013 Jan 31;2(1):2
pubmed: 23369289
Genes Dev. 2002 Jan 1;16(1):6-21
pubmed: 11782440
Nucleic Acids Res. 1983 Oct 11;11(19):6883-94
pubmed: 6314264
Front Cell Dev Biol. 2019 Jan 29;7:4
pubmed: 30761299
Methods Cell Biol. 2009;94:299-313
pubmed: 20362097
Epigenomics. 2011 Jun;3(3):267-77
pubmed: 22122337
Epigenomics. 2015;7(1):103-18
pubmed: 25687470

Auteurs

Nicolò Bozzini (N)

Biomedical Science and Technologies and Nanobiotecnologiy Lab., IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Sofia Avnet (S)

Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy.

Nicola Baldini (N)

Biomedical Science and Technologies and Nanobiotecnologiy Lab., IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy.

Margherita Cortini (M)

Biomedical Science and Technologies and Nanobiotecnologiy Lab., IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH